Document Detail

Effectiveness of tranilast on restenosis after directional coronary atherectomy.
MedLine Citation:
PMID:  9351739     Owner:  NLM     Status:  MEDLINE    
Tranilast is an antiallergic drug used widely in Japan that also inhibits the migration and proliferation of vascular smooth muscle cells. This pilot study was undertaken to determine the effectiveness of tranilast on restenosis after successful directional coronary atherectomy. After the procedure, 40 patients (56 lesions, tranilast group) were treated with oral tranilast for 3 months, and 152 patients (188 lesions, control group) did not receive tranilast. Angiographic and clinical variables were compared between the two groups. The minimal lumen diameter was significantly larger in the tranilast group than in the control group at both 3-month (2.08 vs 1.75 mm, p = 0.004) and 6-month follow-up (2.04 vs 1.70 mm, p = 0.003). The diameter stenosis in the tranilast group was smaller than that in the control group both 3 months (28% vs 40%, p = 0.0007) and 6 months (30% vs 43%, p = 0.0001) after the procedure, with a lower restenosis rate (percent diameter stenosis > or =50) in the tranilast group at 3 months (11 % vs 26%, p = 0.03). The number of clinical events over the 12-month period after the procedure was significantly reduced by tranilast administration (p = 0.013). These findings suggest that the oral administration of tranilast strongly prevents restenosis after directional coronary atherectomy.
K Kosuga; H Tamai; K Ueda; Y S Hsu; S Ono; S Tanaka; T Doi; W Myou-U; S Motohara; H Uehata
Related Documents :
25209209 - Surgical treatment of acute acromioclavicular joint dislocations: hook plate versus min...
20920649 - Usefulness of intravascular low-power laser illumination in preventing restenosis after...
21921099 - Detection of active disease in juvenile idiopathic arthritis: sensitivity and specifici...
18412239 - Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propen...
15582309 - Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous c...
20671639 - Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis...
21718609 - Effectiveness and safety of laparoscopic roux-en-y gastric bypass in treating type 2 di...
23008239 - Rating systems for evaluation of functional ankle instability: prospective evaluation i...
151609 - Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricula...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  134     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1997-11-14     Completed Date:  1997-11-14     Revised Date:  2006-02-27    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  712-8     Citation Subset:  AIM; IM    
Department of Cardiology, Shiga Medical Center for Adult Diseases, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anthranilic Acids / therapeutic use*
Anti-Allergic Agents / therapeutic use*
Atherectomy, Coronary*
Case-Control Studies
Coronary Disease / prevention & control*,  surgery
Middle Aged
Treatment Outcome
Reg. No./Substance:
0/Anthranilic Acids; 0/Anti-Allergic Agents; 53902-12-8/tranilast

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Angioscopic evaluation of angiographically complex coronary lesions.
Next Document:  Trends in success rate after percutaneous transluminal coronary angioplasty in men and women with co...